Wellcon Animal Health Profile
Key Indicators
- Authorised Capital ₹ 2.40 M
as on 23-10-2024
- Paid Up Capital ₹ 0.11 M
as on 23-10-2024
- Company Age 9 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 Cr
as on 23-10-2024
- Revenue 37.24%
(FY 2023)
- Profit 46.51%
(FY 2023)
- Ebitda 42.25%
(FY 2023)
- Net Worth 153.75%
(FY 2023)
- Total Assets 37.64%
(FY 2023)
About Wellcon Animal Health
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.40 M and a paid-up capital of Rs 0.11 M.
The company currently has active open charges totaling ₹4.00 Cr.
Ankur Agarwal and Ashok Agarwal serve as directors at the Company.
- CIN/LLPIN
U33111UP2015PTC067989
- Company No.
067989
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
02 Jan 2015
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Agra, Uttar Pradesh, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Wellcon Animal Health Private Limited offer?
Wellcon Animal Health Private Limited offers a wide range of products and services, including Animal Medicines & Health Care, Veterinary Injections.
Who are the key members and board of directors at Wellcon Animal Health?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ankur Agarwal  | Director | 02-Jan-2015 | Current |
| Ashok Agarwal | Director | 22-Jun-2022 | Current |
Financial Performance and Corporate Structure Insights of Wellcon Animal Health.
Wellcon Animal Health Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 37.24% increase. The company also saw a substantial improvement in profitability, with a 46.51% increase in profit. The company's net worth Soared by an impressive increase of 153.75%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Wellcon Animal Health?
In 2023, Wellcon Animal Health had a promoter holding of 95.00% and a public holding of 5.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Meek Pharma Private LimitedActive 19 years 4 monthsAnkur Agarwal and Ashok Agarwal are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 27 Jul 2022 | ₹4.00 Cr | Open |
How Many Employees Work at Wellcon Animal Health?
Wellcon Animal Health has a workforce of 274 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Wellcon Animal Health, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Wellcon Animal Health's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
